CN Stock MarketDetailed Quotes

688105 Nanjing Vazyme Biotech

Watchlist
  • 23.64
  • +0.10+0.42%
Market Closed Dec 20 15:00 CST
9.51BMarket Cap400.68P/E (TTM)

Nanjing Vazyme Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nanjing Vazyme Biotech Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
336.64M
--
+12.87%
EPS
--
<0.01
--
--
Analyst Rating
Strong Buy

Dec 20, 2024

Nanjing Vazyme Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3298.258M / 308.385M--
Aug 30, 20232023/Q2268.843M / 322.185M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q3298.258M / 308.385M--
Aug 30, 20232023/Q2268.843M / 322.185M--
--------
--------
--------

Unlock Free Earnings Estimates

Nanjing Vazyme Biotech Earnings Reports

  • Novi Zam: third quarter report 2024

    Oct 30 12:00 ET

  • Third Quarter Report 2024

    Oct 30 12:00 ET

  • 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 20, 2024

    Strong Buy

    • Strong Buy

      72.73%

    • Buy

      27.27%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Specialized, Special and New
    Specialized, Special and New
    Intraday+2.45%
    Gene Sequencing
    Gene Sequencing
    Intraday+0.58%
    Medical Device Concept
    Medical Device Concept
    Intraday+0.57%